约克大学团队将在联合国化学品框架会议展示 100 国 2135 个站点的河流药品污染数据
Scientists take global fight against pharmaceutical pollution to landmark UN summit
约克大学与香港城市大学团队对 100 多个国家 370 条河流和河口的 2135 个站点采样,90% 的站点至少检出一种药品,抗癫痫药 carbamazepine 分布最广,见于 77% 的站点。
- 背景
- 药物活性成分进入河流与海洋早已不是新问题,缺的是跨大陆、用同一套方法采出来的可比证据,这也让它在国际化学品治理议程上迟迟难以落位。2023年达成的《全球化学品框架》以预防化学品与废物带来的危害为目标,其首次国际会议在日内瓦召开(11月16—20日),为把药物残留写进政府间承诺提供了一个窗口。约克大学与香港城市大学的团队正是带着全球监测数据到场,主张药物污染没有哪个国家能单独解决,应把环境中的药物浓度压到对人类和地球都安全的水平。
- 做法
- 数据来自两条并行的全球监测线路:约克大学牵头的全球河流调查,与香港城市大学牵头的全球河口监测计划,二者都隶属联合国海洋科学促进可持续发展十年。网络联合了220多家伙伴机构,覆盖各大洲,并在全球采用统一的采样与分析方法,这是让不同大陆的数据得以并置的前提。合并后的数据集包含100多个国家、370条河流与河口的2135个采样点,采样区域居住着约十亿人。在会场,团队用展台、交互式世界地图和50多种语言的国家信息表呈现这些点位,并在 Spotlight Stage 主持「The Big Water Quiz: Pharmaceuticals from Source to Sea」问答,让代表拿研究结论检验自己的认知。团队同时推介今年早些时候发表的两篇论文:一篇在 Environmental Science & Technology 提出「环境安全且公平的药学」框架,另一篇在 npj Emerging Contaminants 把它转成行动方案。约克大学还与 Health Care Without Harm 联合提名「药品污染及其对人类健康与环境的影响」为《全球化学品框架》下的新「关切议题」。
- 结论
- 监测层面:至少90%的采样点检出至少一种药物;抗癫痫药卡马西平分布最广,出现在77%的点位;30%的点位至少有一种化合物超过被认为对水生生物安全的浓度;15%的点位抗生素浓度达到可能促进抗菌药耐药的水平。污染最重的河流与河口主要集中在废水处理能力有限的低收入和中等收入国家。论文层面:框架论文由13位专家撰写,设定4项标准与12项子标准,评估结论是现行实践与这些标准仅部分符合、或符合得很差;路线图论文提出覆盖药物设计、监管、生产、处方、农业以及废物与废水处理的9项管理方案,配6项跨领域支撑行动,并给出2030、2040、2050年的可衡量里程碑。团队提名的「关切议题」是各国将在日内瓦审议的四个新提名之一。
- 机制
- 结果的空间分布指向废水处理这一环。正文把污染最重的河流与河口落在废水处理能力有限的中低收入国家,检出与超标情况的地区差异由此得到解释。方法上的统一是另一半前提:整个网络用同一套方法在全球采集和分析样品,香港城市大学的Kenneth Leung把它比作一次全面体检——方法一致,各地结果才能并置,才能指出污染发生在哪里、热点在哪里、哪些污染物最值得担忧,并据此对症处理。
- 意义
- 这组数据把药品污染从研究议题推到谈判桌上:覆盖100多个国家、2135个点位的可比证据,是「关切议题」提名能够成立的实证基础。若提名获采纳,各国及其他利益相关方将承诺协调的国际行动,可能包括监测、生产与废水管理、更负责任的用药与处置。对监管机构、制药行业与水务部门来说,两篇论文给出的4项标准与12项子标准、9项方案与6项行动,是可逐条对照的条目,而不是笼统呼吁。
- 下一步
- 接下来是日内瓦的政府间程序:该提名是各国将在会议期间审议的四个新提名之一,是否列入「关切议题」尚待决定。若获通过,承诺内容指向监测、制造与废水管理、更负责任的用药与处置。路线图论文已把可衡量里程碑铺到2030、2040与2050年,为后续跟踪标出时间点。


Researchers from the University of York will urge global action to tackle the growing threat of pharmaceuticals contaminating rivers and seas at a major United Nations conference in Geneva.
Working alongside partners at the City University of Hong Kong, the York team will present global monitoring data—spanning more than 2,000 sites across 100 countries—at the first International Conference of the Global Framework on Chemicals (Nov. 16–20).
Prevent harm
The International Conference of the Global Framework on Chemicals is the first meeting under the global agreement adopted in 2023 to prevent harm from chemicals and waste.
The University of York and City University of Hong Kong lead a worldwide network of more than 220 partner organizations that have measured pharmaceuticals in rivers and estuaries on every continent as part of the Global Pharmaceutical Monitoring Project and the Global Estuaries Monitoring Programme under the U.N. Decade of the Ocean Sciences for Sustainable Development.
Throughout the week, the team from York and Hong Kong will run an exhibition booth showing where pharmaceuticals have been found, which medicines pose the greatest risks and what can be done about them. Visitors to the booth will be able to explore the data collected using an interactive world map and pick up information sheets for their own country, available in more than 50 languages.
On the Spotlight Stage, the team will host "The Big Water Quiz: Pharmaceuticals from Source to Sea." In this interactive quiz, delegates will be able to test their knowledge against the findings of the global study and learn about the issue in a fun and informative way.
Global problem
Alistair Boxall, a professor in the University of York's Department of Environment and Geography, said, "Pharmaceutical pollution is a global problem that no country can solve alone.
"This conference is the moment to place the problem on the international agenda to catalyze action to bring concentrations of pharmaceuticals in the environment down to levels that are safe for humans and the planet."
Kenneth Leung, a professor in City University of Hong Kong's State Key Laboratory of Marine Environmental Health, said, "This is a rare international collaboration on this scale, using the same methods to collect and analyze samples worldwide. The results show where pharmaceutical pollution is occurring, where the hot spots are and which contaminants are of greatest concern—much like a thorough health checkup that identifies problems so they can be treated."
At the conference, the team will promote two papers published earlier this year that set out how the world can keep the benefits of medicines while cutting their harm to nature.
The first, in Environmental Science & Technology, sets out a framework for an "Environmentally Safe and Just Pharmacy." Written by 13 experts from around the world, it sets four criteria and 12 subcriteria that need to be met for the pharmaceutical life cycle to be safe for the planet. It finds that current practice only partly or poorly aligns with the criteria.
The second, in npj Emerging Contaminants, turns this into action. It sets out nine management solutions spanning drug design, regulation, manufacturing, prescribing, agriculture, and waste and wastewater treatment. Six cross-cutting actions support them, with measurable milestones for 2030, 2040 and 2050.
The University of York and Health Care Without Harm jointly nominated "Pharmaceutical pollution and its effects on human health and the environment" as a new Issue of Concern under the Global Framework. It is one of four new nominations that governments will consider in Geneva (UNEP).
Responsible use
If it is adopted, countries and other stakeholders would commit to coordinated international action on the problem. This could include monitoring, better management of manufacturing and wastewater, and more responsible use and disposal of medicines.
The case rests on the Global Pharmaceutical Monitoring Project, one of the largest studies of its kind. It brings together the global river survey led by York and the Global Estuaries Monitoring Programme led by City University of Hong Kong. Between them, these studies cover 2,135 sites on 370 rivers and estuaries in more than 100 countries.
The areas sampled are home to about a billion people.
- At least one pharmaceutical was found at 90% of sites.
- The antiepilepsy drug carbamazepine was the most widespread, found at 77% of sites.
- At 30% of sites, at least one compound was above a level considered safe for aquatic life.
- At 15% of sites, antibiotics were at levels that could encourage antimicrobial resistance.
- The most contaminated rivers and estuaries were mainly in low- and middle-income countries, where wastewater treatment is limited.
The data can be explored at globalpharms.org and globalestuaries.org.
Publication details
Alistair B. A. Boxall et al., Environmentally Safe and Just Pharmacy: A Framework and Action Plan for Operating within the Earth System Boundary for Novel Entities, Environmental Science & Technology (2026). DOI: 10.1021/acs.est.5c13062
Alistair B. A. Boxall, Achieving environmentally safe and just pharmacy: a global roadmap to address the global challenge of pharmaceutical pollution, npj Emerging Contaminants (2026). DOI: 10.1038/s44454-026-00066-w
Citation: Scientists take global fight against pharmaceutical pollution to landmark UN summit (2026, November 17) retrieved 17 November 2026 from https://phys.org/news/2026-11-scientists-global-pharmaceutical-pollution-landmark.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Phys.org · phys.org